New anti-cancer drug developed by Peking University and Qizheng Tibetan drug enters phase i-phase clinical
-
Last Update: 2020-07-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The treatmenttumordrug ethaneselium, developed jointly by Peking University and Gansu Qizheng Pharmaceutical Co., Ltd., has recently beenby the State Administration of FoodDrugsupervision and, andenter the first phase of clinical researchThis isby the original innovationof Chinese scientists,a number of domestic invention patent grant protection,and has applied for international patent protection with fully independent intellectual property rights,to treattumorinnovative drugs A series of studies have been completed to show that , ethane selenium drugs have a inhibitory effect on a variety of tumors such as lung cancer , colon cancer , stomach cancer
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
